Vanda Pharmaceuticals | VNDA - تكلفة المبيعات





تكلفة المبيعات تغيير تاريخ
Acadia Pharmaceuticals USD 24.79M 1.43M 2026-03
Agios Pharmaceuticals USD 1.32M 560K 2026-03
Akebia Therapeutics USD 10.34M 441K 2025-12
Alnylam Pharmaceuticals USD 211.12M 56.6M 2026-03
Anika Therapeutics USD 11.44M 797K 2025-12
AstraZeneca USD -204M 3.48B 2026-03
Bristol-Myers Squibb USD 3.86B 1.07B 2026-03
Eli Lilly USD 3.58B 205M 2026-03
Esperion Therapeutics USD 27.85M 13.43M 2025-12
Halozyme Therapeutics USD 108.75M 6.6M 2026-03
Heron Therapeutics USD 11.12M 795K 2025-12
Insmed USD 49.5M 3.34M 2026-03
J&J USD 8.07B 103M 2026-03
Lexicon Pharmaceuticals USD 201K 191K 2025-12
Ligand Pharmaceuticals USD 11.37M 8.38M 2026-03
Merck USD 2.94B 380M 2026-03
Minerva Neurosciences 386K 31K 2024-06
Moderna USD 955M 503M 2026-03
Novartis USD 3.46B 83M 2026-03
Pfizer USD 4.59B 1.7B 2026-03
PTC Therapeutics USD 39.61M 23.31M 2026-03
Puma Biotechnology USD 29.1M 18.44M 2024-09
Sangamo BioSciences 2.42M 1.11M 2024-06
Sanofi EUR 3.67B 621M 2026-03
Takeda JPY 560.54B 159.39B 2026-03
Teva Pharmaceutical Industries USD 2.01B 46M 2026-03
Ultragenyx Pharmaceutical USD 30M 1000K 2026-03
Vanda Pharmaceuticals USD 198.77M 151.12M 2024-12
Veracyte USD 38.49M 794K 2026-03